Financials data is unavailable for this security.
View more
Year on year Safeguard Scientifics Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 14.26m to a smaller loss of 9.83m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -32.47% |
|---|---|
| Return on equity | -36.03% |
| Return on investment | -34.69% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Safeguard Scientifics Inc fell by 3.84m. However, Cash Flow from Investing totalled 5.72m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 3.31m for operations while cash used for financing totalled 6.25m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.20 |
|---|---|
| Tangible book value per share | 1.20 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.84 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 30.60%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 30.42 |
